Heramed Ltd · ASX:HMD
Heramed — Investor Presentation (December 2018)
23 slides from Heramed's investor presentation, Dec 19, 2018
Slide 1: Investor Presentation December 2018
Investor Presentation | December 2018 a FHR MHR a7 |O2 / 4 ' ! RA @ ) B Bonham, Rolanda (22) WEEK 22 starts A = M E D : — WEEK 217 The beat of life fr ACN 626 295 314 ASX:HMD
Slide 2: Disclaimer
DISCLAIMER This document contains 6 general summary of he company ond is provided for information purposes only. For fll details please review the Prospectus issued on23 November 2018 by HeroMED Limited ACN 626 295 314 |HeroMED) -hiips:/Avww.ase.com.av/asxpdl/20181210/pdt/44 13gcs992kjsx.pdl, This d
Slide 3: HeraBEAT: The Smart, Medical Grade, Home Pregnancy Monitoring Solution
For personal use only HeraBEAT: The Smart, Medical Grade, Home Pregnancy Monitoring Solution. HERA @ MED @
Slide 4: The World's Most Advanced, Smart, Medical Grade, Home Pregnancy Monitoring Solution
The World’s Most Advanced, Smart, Medical Grade, Home Pregnancy Monitoring Solution. | LEADING PREGNANCY CARE | _ Improving Mother & Baby Wellness | | Empowering Personalized, Proactive Care | Reshaping Doctor/ Patient Relationship | | | | | } ee oe Providing Better Care at Lower Cost
Slide 5: The Problem with Monitoring
THE PROBLEM WITH MONITORING IT HASN'T CHANGED SINCE THE 50'S Ps : Pag DOCTORS/ PROVIDERS EXPECTING MOTHERS YY Shortage of fundamental services @® 14+ clinical sessions per pregnancy ® — Lack of time and attention &al_ Loss of time away from work / child care b= — Low reliability of analysis Personal
Slide 6: End-to-End Medical Grade Solution
END-TO-END MEDICAL GRADE SOLUTION PROVIDING CONTINUOUS TRACKING & TREND BASED ANALYSIS 2oaokt#r96a Affordable Continuous Home use Accurate Reliable Personal
Slide 7: Technological Ecosystem
TECHNOLOGICAL ECOSYSTEM HeraBEAT HeraBEAT App Optimized Medical MultiSensor Unit Unique & Proprietary UX For Home Use Cloud Immediate Actionable Physician Response Analysis Dashboard App
Slide 8: Company IP
COMPANY IP Hardware and Sensor IP Optimized | | } Foetal HR | Doppler | Maternal HR Optical Sensor a Ultrasound Motion Detection Sensors ie Pending Hypersensitive ee patents CE Approved (by BSI) TGA Approved FDA Planned for 2019 - For Foetal HR Software and Algorithm IP Hospital Quality Foetal Strip
Slide 9: Business Models
BUSINESS MODELS 2019 HeraBEAT HeraCARE Orion Al | | | | | MultitSensor Service + Cloud SaaS + Dashboard | $US299 MSRP $US9.9/Mo $US1.9 Per Analysis | | Proprietary Home 24/7 Call Centre A.|. Powered Pregnancy Monitoring Device Premium Pregnancy Support Monitoring Analysis | Addressable Annual Market
Slide 10: Market Segments
MARKET SEGMENTS VERTICAL IMPACT HOMECARE Improve Mother/Baby Wellness Empower Pregnant Woman & Reduce Anxiety Early Warning In Case Of Complications Reduce Unnecessary Clinic Visits Let Professionals Practice “Real” Medicine Increase Patient Satisfaction HMOS/ INSURERS Save Expenses Strategic Engage
Slide 11: For personal use only
For personal use only • • • • • • • • • • 11
Slide 12: For personal use only
For personal use only • • • • • • • • • • • • • • 12
Slide 13: For personal use only
For personal use only • • • • • • • • • • • • • 13
Slide 14: For personal use only
For personal use only ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 14
Slide 15: HeraBEAT vs Philips fetal heart rate
For personal use only • • • 220 210 210 200 190 190 180 170 170 160 Fetal Heart rate [BPM] Fetal Heart rate [BPM] 150 150 140 Philips 130 Philips 130 HeraBEAT 120 HeraBEAT 110 110 100 90 90 80 70 70 60 50 50 00:21.0 00:51.0 01:21.0 01:51.0 02:21.0 02:51.0 03:21.0 00:00.0 00:30.0 01:00.0 01:30.0 02:0
Slide 16: Orion AI: The Challenge
ORION AI: THE CHALLENGE At Hospital or at Home, Pregnancy monitoring always requires the careful attention of a trained OB/GYN for a subjective, time consuming, visual analysis of FHR pattern recognition and wellbeing assessment: Social and Financial cost: The average total price charged for pregnan
Slide 17: For personal use only
For personal use only • • • • • • • • 18
Slide 18: For personal use only
For personal use only • • • • • 19
Slide 19: For personal use only
For personal use only 2011 - 2013 2014 - 2015 2016 2017 2018 2019 2020 2021 20
Slide 20: For personal use only
For personal use only • • May • 2018 • Jan • 2018 • Mar • 2017 • 21
Slide 21: Board of Directors
BOARD OF DIRECTORS ® g e Dr. Ron Weinberger — Non-Executive Chairman Highly experienced business executive, with strong scientific background and international span| Ex president and CEO of Nanosonics Lid. ASX: NAN, Mkt cap ~$AUD 980 Million David Groberman — CEO, Co-Founder and Executive Director:
Slide 22: Investment Summary
PO INVESTMENT SUMMARY HeraMED raised A$6 Million to fund commercialisation strategy: The Company also has 23m deferred consideration shares and 23.6m options on issue exercisable at $0.25 with various expiry dates The deferred consideration shares vest upon: | 1. Obtaining US Federal Drug Administra
Slide 23: Thank you
"An individual's lifetime health and disease is most probably programmed at a very early stage — while a child is still in the womb” The Origins Project (Part of Ramsay Health) HERA @ MED a Thank you David Groberman | CEO & Co-Founder Mobile +972-52-699 1 188 David@Hera-Med.com a